Development of a trivalent epitope-focused RSV vaccine to boost pre-existing immunity

Project Information

RSVTriVax

Grant agreement ID: 862291

DOI

10.3030/862291

Project closed

EC signature date 21 August 2019

Start date 1 October 2019

End date 30 September 2021

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost

No data

EU contribution

€ 150 000,00

Coordinated by

ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE
Switzerland

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

De novo protein design enables the precise induction of RSV-neutralizing antibodies

Author(s): Fabian Sesterhenn , Che Yang, Jaume Bonet , Johannes T Cramer, Xiaolin Wen, Yimeng Wang, Chi-I Chiang , Luciano A Abriata , Iga Kucharska, Giacomo Castoro, Sabrina S Vollers , Marie Galloux, Elie Dheilly, Stéphane Rosset , Patricia Corthésy , Sandrine Georgeon , Mélanie Villard , Charles-Adrien Richard, Delphyne Descamps, Teresa Delgado, Elisa Oricchio , Marie-Anne Rameix-Welti , Vicente Más ,
Published in: Science, 2020, ISSN 0036-8075
Publisher: American Association for the Advancement of Science
DOI: 10.1126/science.aay5051

Intellectual Property Rights

Patent (1)

IMMUNOGEN

Application/Publication number: 19 183026
Date: 2019-06-27
Applicant(s): ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE